Concepedia

Marina V. Karg

MV

8

Publications

612

Citations

8

H-Index

2017

Active since

Affiliations

Friedrich-Alexander-Universität Erlangen-Nürnberg(Current)

Universitätsklinikum Erlangen

Paracelsus Medizinische Privatuniversität

IPPMed (Germany)

Marina V. Karg is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in diabetes, metabolic syndrome, and physiology.

Top concepts

Publications per year

2017–2023

8

Publications

8

SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial

Marina V. Karg, Agnes Bosch, Dennis Kannenkeril et al. · Cardiovascular Diabetology · 2018 · 180 citations · Full text

A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation

Christian Ott, Agnes Jumar, Kristina Striepe et al. · Cardiovascular Diabetology · 2017 · 138 citations · Full text

How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial

Agnes Bosch, Christian Ott, Susanne Jung et al. · Cardiovascular Diabetology · 2019 · 109 citations · Full text

Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications

David E. Kandzari, Raymond R. Townsend, Kazuomi Kario et al. · Journal of the American College of Cardiology · 2023 · 93 citations

Tissue sodium content in patients with type 2 diabetes mellitus

Dennis Kannenkeril, Marina V. Karg, Agnes Bosch et al. · Journal of Diabetes and its Complications · 2019 · 33 citations

, , +7

Rows per page

1–5 of 8